Multiple opioid receptors.
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001575:Benzomorphans / Q000031:analogs & derivatives / Q000627:therapeutic use; D003496:Cyclazocine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D004193:Discrimination Learning / Q000187:drug effects; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004361:Drug Tolerance; D004569:Electroencephalography; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D009020:Morphine / Q000494:pharmacology* / Q000627:therapeutic use; D009021:Morphine Dependence / Q000188:drug therapy; D009043:Motor Activity / Q000187:drug effects; D009269:Nalorphine / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects*; D017473:Receptors, Opioid, kappa; D012640:Seizures / Q000188:drug therapy; D013696:Temperature
D000700:Analgesics; D001575:Benzomorphans; D011954:Receptors, Dopamine; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; C014716:normetazocine; D009020:Morphine; C027248:bremazocine; D003496:Cyclazocine; D009269:Nalorphine; D004298:Dopamine